Keywords: سیتوکروم پی۴۵۰; AC; adenyl cyclase; AD; Alzheimer's disease; 2-AG; 2-arachidonoylglycerol; ABHD6; α,β hydrolase 6; AEA; arachidonylethanolamide/anandamide; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; cAMP; cyclic adenosine monophosphate; CBD; cannabid
مقالات ISI سیتوکروم پی۴۵۰ (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Rational design of metalloenzymes: From single to multiple active sites
Keywords: سیتوکروم پی۴۵۰; UAAs; unnatural amino acids; Rd; rubredoxin; EPR; electron paramagnetic resonance; Az; azurin; SOR; superoxide reductase; PDB; protein data bank; 6-PGLac; 6-phosphogluconolactonase; H-bond; hydrogen-bond; NIR; nitrite reductase; ET; electron transfer; 3SC
Keywords: سیتوکروم پی۴۵۰; CYP; Cytochrome P450; NAPQI; N-acetyl-p-benzoquinone imine; NEC; Necrotizing enterocolitis; NIAPAS; Neonatal Infant Acute Pain Assessment Scale; NICU; Neonatal intensive care unit; PDA; Patent ductus arteriosus; VLGA; Very low gestational age;
Keywords: سیتوکروم پی۴۵۰; Cytochrome P450; drug interactions; P-glycoprotein; pharmacodynamics; pharmacokinetics; polypharmacy
Keywords: سیتوکروم پی۴۵۰; Lipid apheresis; Hyperlipoproteinaemia; Gas chromatography; Oxylipine; Lipidomic; LC/ESI-MS/MS; PUFA; n-3-PUFA; omega-3 polyunsaturated fatty acids; n-6-PUFA; omega-6 polyunsaturated fatty acids; EPA; eicosapentaenoic acid; DHA; docosahexaenoic acid; AA;
Keywords: سیتوکروم پی۴۵۰; Natural products; Dietary supplements; Herbal medicines; Drug interactions; Cytochrome P450; Transporters; Metabolic enzymes; CYP450; cytochrome P450; Cmax; maximum concentration; DDI; drug-drug interactions; MDP; methylenedioxyphenyl; NP; natural produ
Keywords: سیتوکروم پی۴۵۰; Clopidogrel; PPI's; Statins; Antiplatelets; Platelet aggregation; Cytochrome P450; Potential drug â drug interaction;
Keywords: سیتوکروم پی۴۵۰; ROS; Reactive oxygen species; CYP; cytochrome P450; GST; glutathione S-transferases; NAT; N-acetyltransferase; UCP; Uncoupled proteins; Ala; Alanine; Val; Valine; Thr; Threonine; PCR; Polymerase chain reaction; RFLP; Restriction Fragment Length Polymorphi
Keywords: سیتوکروم پی۴۵۰; Cytochrome P450; Glutathione S transferase; Carboxylesterase; Host suitability; Diet mixing
Keywords: سیتوکروم پی۴۵۰; PCBs; Low dose; Food matrix; Mitochondria; Oxidative stress; AhR; Aryl hydrocarbon receptor; ASAT; Aspartate aminotransferase; ALAT; Alanine aminotransferase; CYP; Cytochrome P450; DL-PCBs; Dioxin-like PCBs; PCB-I; Indicator PCBs; NDL-PCBs; Non-Dioxin-lik
Keywords: سیتوکروم پی۴۵۰; AHR; aryl hydrocarbon receptor; AP-1; activator protein 1; ARNT; AHR nuclear translocator; BAD; Bcl-2-associated death promoter; CYP; cytochrome P450; DRE; dioxin-responsive element; ERK; extracellular signal-regulated kinase; FICZ; 6-formylindolo (3,2-b)
Keywords: سیتوکروم پی۴۵۰; ChIP; chromatin immunoprecipitation; CRP; C-reactive protein; CYP; cytochrome P450; E2; estradiol; E2S; estradiol sulfate; EMSA; electrophoretic mobility shift assay; ER; estrogen receptor; EST; estrogen sulfotransferase; FBS; fetal bovine serum; HPH; hum
Keywords: سیتوکروم پی۴۵۰; Predicting human PK; Minipig; Vd; CL; Physiological parameters; Single-species prediction; Allometric scaling approaches; AFE; average-fold error; CLb; whole blood clearance; CLp; plasma clearance; CYP; cytochrome P450; fup; unbound fraction in plasma; fu
Keywords: سیتوکروم پی۴۵۰; AcHz; acetylhydrazine; AcINH; acetylisoniazid; ALP; alkaline phosphatase; ALT; alanine aminotransferase; DiAcHz; diacetylhydrazine; GSH; glutathione; GST; glutathione S-transferase; Hz; hydrazine; INA; isonicotinic acid; INH; isoniazid; MPO; myeloperoxida
Keywords: سیتوکروم پی۴۵۰; Chlordecone; Chinese rare minnow (Gobiocypris rarus); Endocrine disruption; Adverse outcome pathway (AOP); AOP; Adverse Outcome Pathway; MIE; Molecular Initiating Event; KE; Key Event; AO; Adverse Outcome; T; Testosterone; E2; Estradiol; ER; Estrogen Rece
Keywords: سیتوکروم پی۴۵۰; AUC; area under the curve; CPIC; Clinical Pharmacogenetics Implementation Consortium; CYP; cytochrome P450; EM; extensive metabolizer; FDA; US Food and Drug Administration; OCD; obsessive-compulsive disorder; PM; poor metabolizer; QIDS-C16; Quick Inventor
Keywords: سیتوکروم پی۴۵۰; BHBH; beta-hydroxy butyric acid; CD36; cluster of differentiation 36; CL; corpus luteum; CREB-CBP; cAMP regulatory element-binding protein complex; CCND2; cyclin-D2; CYP11A1; cytochrome P450, family 11, subfamily A, polypeptide 1; CYP19A1; cytochrome P450
Keywords: سیتوکروم پی۴۵۰; Nonalcoholic fatty liver disease; Liver gene expression; Drug metabolizing enzymes; Cytochrome P450;
Keywords: سیتوکروم پی۴۵۰; AUC; area under the plasma concentration-time curve; B/P; blood-to-plasma ratio; CYP; cytochrome P450; CLint; intrinsic clearance; Cmax; maximum plasma concentration; CLPD; passive permeability-surface area product; DDI; drug-drug interaction; fa; fract
Keywords: سیتوکروم پی۴۵۰; BL-1; Basal like 1; BL-2; Basal like 2; BRCA-1; Breast cancer 1; BCRP; Breast cancer resistant protein; BCSC; Breast cancer stem cell; CYP; Cytochrome P450; D-2HG; D-2-hydroxyglutarate; DCA; Dichloroacetic acid; DHEA; Dehydroepiandrosterone; ER; Estrogen
Keywords: سیتوکروم پی۴۵۰; Extracellular matrix; Human embryonic stem cell; Human induced pluripotent stem cell; Hepatic differentiation; Laminin-511; Laminin-521; ACM; acellular matrix; Act A; Activin A; AAT; alpha-1 antitrypsin; AFP; alpha fetoprotein; ALB; albumin; AhR; aryl hyd
Keywords: سیتوکروم پی۴۵۰; Antihypertensive; Pharmacogenomics; Implementation; Cytochrome P450;
Keywords: سیتوکروم پی۴۵۰; CAF; cancer-associated fibroblast; COX; cyclooxygenase; CYP; cytochrome P450; ECM; extracellular matrix; EMT; epithelial-to-mesenchymal transition; GPx; glutathione peroxidase; HIF-1; hypoxia-inducible transcription factor-1; JNK; c-Jun NH2-terminal kinas
Keywords: سیتوکروم پی۴۵۰; Therapeutic drug monitoring; Antipsychotic; Antidepressant; Psychopharmacology; Psychiatry; Psychopharmacotherapy; Pharmacokinetics; HPLC; Mass spectrometry; LC-MS/MS; ABCB1; ATP-binding cassette sub-family B member 1; AGNP; Arbeitsgemeinschaft für Neuro
Keywords: سیتوکروم پی۴۵۰; CS; cigarette smoke; E2; 17β-estradiol; NSC; no-smoke control; ROS; reactive oxygen species; MMP; matrix metalloproteinases; COPD; chronic obstructive pulmonary disease; TIMP; tissue inhibitor of metalloproteinases; ECM; extracellular matrix; ER; estroge
Keywords: سیتوکروم پی۴۵۰; Pain; Diarrhea; Constipation; Animal Models; Dyspepsia; Transit; Sensation; CFTR; cystic fibrosis transmembrane regulator; cGMP; cyclic guanosine monophosphate; CYP; cytochrome P450; FD; functional dyspepsia; FDA; Food and Drug Administration; FGID; funct
Keywords: سیتوکروم پی۴۵۰; PAPS; 3â²-Phosphoadenosine 5â²-phosphosulfate; DTNB; 5,5â²-Dithiobis(2-nitrobenzoic acid); APAP; Acetaminophen; ALT; Alanine aminotrasferase; BSA; Bovine serum albumin; CCl4; Carbon tetrachloride; Ccr2; C-C chemokine receptor 2; CFB; Clofibrate; CD;
Keywords: سیتوکروم پی۴۵۰; CYP46A1; Cytochrome P450; Brain cholesterol; Neuronal function; Neurodegeneration; 24 (S)-hydroxycholesterol;
Keywords: سیتوکروم پی۴۵۰; 17β-HSD; 17-beta hydroxysteroid dehydrogenase; MLHI; MutL Ecoli homolog 1; 2,5-HD; 2,5-n-hexandione; MMPs; Matrix metalloproteinases; AHr; Aryl Hydrocarbon receptor; MRP1; Multi-drug Resistance protein 1; Akr1c; Aldo-keto reductase family; NF-κβ; Nucle
Keywords: سیتوکروم پی۴۵۰; Bosentan; Perfluorinated analogues; Metabolic specificity; Phase I metabolism; HLM; Cl; Clearance; CYP; Cytochrome P450; DDI; drug-drug interactions; ERA; Endothelin Receptor Antagonist; ET-1; Endothelin 1; ETA; Endothelin receptor A; ETB; Endothelin rece
Keywords: سیتوکروم پی۴۵۰; ABCB; ATP-binding cassette sub-family B; Apo; apolipoprotein; ASBT; apical sodium dependent bile acid transporter; BDL; bile duct ligation; BSEP; bile salt export pump; CA; cholic acid; CDCA; chenodeoxycholic acid; C/EBP; CCAAT-enhancer-binding protein; C
Keywords: سیتوکروم پی۴۵۰; ERRγ inverse agonist; Nuclear receptor; ADMET; GSK5182; 4-OHT; 4-hydroxytamoxifen; ADMET; absorption, distribution, metabolism, excretion, and toxicity; CYP; cytochrome P450; DCM; dichloromethane; DES; diethylstilbestrol; ER; estrogen receptor; ERR; estr
Keywords: سیتوکروم پی۴۵۰; ALT; alanine aminotransferase; APAP; acetaminophen; ConA; concanavalin A; CYP; cytochrome P450; ET; endotoxin; FasL; Fas ligand; Gal; D-galactosamine; GSH; glutathione; IFNγ; interferon γ; NAPQI; N-acetyl-p-benzoquinone imine; p-JNK; c-jun N-terminal ki
Keywords: سیتوکروم پی۴۵۰; Cytochrome P450; hepatic failure; liver; metabolism; paracetamol overdose; pharmacokinetics
Keywords: سیتوکروم پی۴۵۰; MS; mass spectrometry; GC; gas chromatography; LC; liquid chromatography; BBB; blood brain barrier; CYP; cytochrome P450; 24S-HC; 24S-hydroxycholesterol; 26-HC; (25R)26-hydroxycholesterol; 7αH,3O-CA; 7α-hydroxy-3-oxocholest-4-enoic acid; 3β,5α-diHC-6O
Keywords: سیتوکروم پی۴۵۰; ANOVA; analysis of variance; CPR; cytochrome P450 reductase; DAMGO; [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin acetate; GTPγS; guanosine 5â²-O-(3-thiotriphosphate) tetralithium salt; icv; intracerebroventricular; Null; neuronal cytochrome P450 reductase de
Keywords: سیتوکروم پی۴۵۰; AUC; area under the curve; API; active pharmaceutical ingredient; SRL; Sirolimus; CYP; cytochrome P450; PgP; P-glycoprotein; FaSSIF/FeSSIF; Fasted/Fed State Stimulating Intestinal fluid; PAMPA; parallel artificial membrane permeation assay; SDS; sodium do
Keywords: سیتوکروم پی۴۵۰; CSF; cerebrospinal fluid; CYP; cytochrome P450; LXRs; liver X receptors; 7α,25-diHC; 7α,25-dihydroxycholesterol (cholest-5-ene-3β,7α,25-triol); 26-HC; (25R)26-hydroxcholesterol,(cholest-5-en-3β,(25R)26-diol); BBB; blood brain barrier; CNS; central ne
Keywords: سیتوکروم پی۴۵۰; Pig; Androstenone; Cytochrome P450; Skatole; Tannins
Keywords: سیتوکروم پی۴۵۰; 2-OH-NVP; 2-hydroxy-nevirapine; 3-OH-NVP; 3-hydroxy-nevirapine; 8-OH-NVP; 8-hydroxy-nevirapine; 12-OH-NVP; 12-hydroxy-nevirapine; cART; combined antiretroviral therapy; CYP; cytochrome P450; EGTA; ethylene glycol tetraacetic acid; Ex-Lum; extraluminal; GI
Keywords: سیتوکروم پی۴۵۰; CI; confidence interval; CYP; cytochrome P450; HR; hazard ratio; NAION; nonarteritic anterior ischemic optic neuropathy; NHI; National Health Insurance; NHIRD; National Health Insurance Research Database; OSA; obstructive sleep apnea; SD; standard deviati
Keywords: سیتوکروم پی۴۵۰; Antiepileptic drugs; Drug interactions; Drug information; Compendia; Cytochrome P450;
Keywords: سیتوکروم پی۴۵۰; MMP; mitochondrial membrane potential; H2DCF-DA; 2â²,7â²-dichlorodihydrofluorescein diacetate; CYPs; cytochrome P450; Antioxidants; Resveratrol; Endothelial cells; Pro-oxidant effect; Cell damage;
Keywords: سیتوکروم پی۴۵۰; Celecoxib; Pharmacokinetics; Genetic polymorphism; Cytochrome P450; Hydroxy-celecoxib; Carboxy-celecoxib;
Keywords: سیتوکروم پی۴۵۰; Malaria; Apicoplast; Cytochrome P450; Clarithromycin; Mefloquine
Keywords: سیتوکروم پی۴۵۰; Rhabdomyolysis; Acute kidney injury; Oxidative stress; Catalytic iron; l-Carnitine; Cimetidine; Cytochrome P450;
Keywords: سیتوکروم پی۴۵۰; BrS; Brugada syndrome; ECG; electrocardiogram/electrocardiographic; Het-EM; heterozygous extensive metabolizer; Hom-EM; homozygous extensive metabolizer; QTc; corrected QT; SD; sudden death; Brugada syndrome; Electrocardiogram; Provocative testing; Flecai
Keywords: سیتوکروم پی۴۵۰; Carbon-based electrode; Cytochrome P450; Electrochemistry; Gold electrode; Metalloporphyrin; Modified electrode; Oxidative drug metabolism; Self-assembly monolayer; Surface modification; Surface-modified electrode
Keywords: سیتوکروم پی۴۵۰; Bioactivation; Biotransformation; Cytochrome P450; Drug development; Drug discovery; Drug metabolism; Electrochemical generation; Electrochemistry; Metabolite synthesis; Reactive metabolite
Keywords: سیتوکروم پی۴۵۰; Batch cell; Cytochrome P450; Drug metabolism; Drug oxidation; Electrochemistry; Electrode material; Electrosynthesis; Flow-through cell; Metabolite; Preparative synthesis